Skip to content
Home/Companies/Biotech/Carrick Therapeutics
Carrick Therapeutics

Carrick Therapeutics

Biotech·Ireland·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Carrick Therapeutics?

Carrick Therapeutics is currently owned by Rosetta Capital through Rosetta Capital V (2021 vintage), since 2021. Across its history, Carrick Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-06-21

Rosetta Capital
Most recent investor
Rosetta Capital
Rosetta Capital V · 2021 · Secondaries
2 ownership periods · full history below

Key facts

HQUK
SectorBiotech
StatusActive

Ownership history

2 ownership periods · co-invest detected

Active
Co-invest · 2 holders · 2016 · present
Cambridge Innovation Capital
2016 · present(10yr) · CIC Fund I · 2013 · VC
Rosetta Capital
2021 · present(5yr) · Rosetta Capital V · 2021 · Secondaries
Track Carrick Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Carrick Therapeutics?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Carrick Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue